e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort
Ane Aamli Gagnat, Miriam Gjerdevik, Frode Gallefoss, Harvey O. Coxson, Amund Gulsvik, Per Bakke
Source:
Eur Respir J, 49 (5) 1601162; 10.1183/13993003.01162-2016
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ane Aamli Gagnat, Miriam Gjerdevik, Frode Gallefoss, Harvey O. Coxson, Amund Gulsvik, Per Bakke. Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort. Eur Respir J, 49 (5) 1601162; 10.1183/13993003.01162-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Prevalence of bronchiectasis in a lung cancer screnning program
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Emphysema, airway obstruction and prognosis in lung cancer
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
The burden of emphysema on lung cancer prognosis
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis
Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020
Year: 2020
Systemic inflamation and bronchial dysplasia in risk lung cancer subjects
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
The Asian experience in co-existing lung cancer and interstitial lung disease
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study
Source: Eur Respir J 2002; 19: 1093-1098
Year: 2002
Bronchial colonisation in patients with lung cancer: a prospective study
Source: Eur Respir J 2013; 42: 220-229
Year: 2013
Outcomes of pulmonary rehabilitation after lung resection in patients with lung cancer
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Bilateral lung cancer with COPD or metastatic disease
Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology
Year: 2016
Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Spirometry and under-diagnosis of COPD in a lung cancer screening cohort
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer
Source: Eur Respir J 2016; 48: 1743-1750
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept